Business Description
Athanase Innovation AB
ISIN : SE0018014060
Compare
Compare
Traded in other countries / regions
ATIN.SwedenH6H.Germany IPO Date
2017-05-08Description
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.8 | |||||
9-Day RSI | 57.18 | |||||
14-Day RSI | 58.11 | |||||
3-1 Month Momentum % | 18.06 | |||||
6-1 Month Momentum % | -5.56 | |||||
12-1 Month Momentum % | -1.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.13 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 102.08 | |||||
OCF Margin % | 102.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Athanase Innovation AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 42.362 | ||
| EPS (TTM) (kr) | 945.104 | ||
| Beta | -0.6719 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 50.71 | ||
| 14-Day RSI | 58.11 | ||
| 14-Day ATR (kr) | 0.405763 | ||
| 20-Day SMA (kr) | 17.18 | ||
| 12-1 Month Momentum % | -1.73 | ||
| 52-Week Range (kr) | 10 - 23 | ||
| Shares Outstanding (Mil) | 24.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Athanase Innovation AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Athanase Innovation AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-04 | In 130 days | ||
| Second quarter earnings results for 2026 | 2026-07-10 | In 13 days | ||
| General meeting for 2026 | 2026-05-07 13:00 | 16.20 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 16.20 (+0.00%) | ||
| Annual report for 2025 | 2026-04-15 | 14.40 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 13.90 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-04 | 20.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-07-11 | 16.20 (+0.00%) | ||
| General meeting for 2025 | 2025-05-07 13:00 | 19.00 (+4.40%) | ||
| First quarter earnings results for 2025 | 2025-05-06 | 20.20 (+0.00%) |
Show
Entries
Athanase Innovation AB Frequently Asked Questions
What is Athanase Innovation AB(OSTO:ATIN)'s stock price today?
The current price of OSTO:ATIN is kr17.80. The 52 week high of OSTO:ATIN is kr23.00 and 52 week low is kr10.00.
When is next earnings date of Athanase Innovation AB(OSTO:ATIN)?
The next earnings date of Athanase Innovation AB(OSTO:ATIN) is 2026-07-10 Est..
Does Athanase Innovation AB(OSTO:ATIN) pay dividends? If so, how much?
Athanase Innovation AB(OSTO:ATIN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Athanase Innovation AB
No articles.